Zobrazeno 1 - 10
of 270
pro vyhledávání: '"Mikko, Haapio"'
Autor:
Wisam Bitar, Jaakko Helve, Mari Kanerva, Eero Honkanen, Virpi Rauta, Mikko Haapio, Patrik Finne
Publikováno v:
PLoS ONE, Vol 18, Iss 6, p e0286579 (2023)
ObjectivesInfections are the most common non-cardiovascular cause of death among dialysis patients. Earlier studies have shown similar or higher risk of infectious complications in peritoneal dialysis (PD) compared to hemodialysis (HD) patients, but
Externí odkaz:
https://doaj.org/article/62f9932fe1ff424fbe3d1f872372480e
Autor:
Mikko Haapio, Merel van Diepen, Retha Steenkamp, Jaakko Helve, Friedo W. Dekker, Fergus Caskey, Patrik Finne
Publikováno v:
PLoS ONE, Vol 18, Iss 2 (2023)
Background Mortality prediction is critical on long-term kidney replacement therapy (KRT), both for individual treatment decisions and resource planning. Many mortality prediction models already exist, but as a major shortcoming most of them have onl
Externí odkaz:
https://doaj.org/article/620c28f529934a6f8d91b7acaaceaba7
Autor:
Toni Jäntti, Tuukka Tarvasmäki, Veli-Pekka Harjola, Kari Pulkki, Heidi Turkia, Tuija Sabell, Heli Tolppanen, Raija Jurkko, Mari Hongisto, Anu Kataja, Alessandro Sionis, Jose Silva-Cardoso, Marek Banaszewski, Salvatore DiSomma, Alexandre Mebazaa, Mikko Haapio, Johan Lassus, for the CardShock investigators
Publikováno v:
Annals of Intensive Care, Vol 11, Iss 1, Pp 1-15 (2021)
Abstract Background Acute kidney injury (AKI) is a frequent form of organ injury in cardiogenic shock. However, data on AKI markers such as plasma proenkephalin (P-PENK) and neutrophil gelatinase-associated lipocalin (P-NGAL) in cardiogenic shock pop
Externí odkaz:
https://doaj.org/article/f5fab8575e374934a408aecf1bb61d22
Autor:
Eric A. Hoste, Suvi T. Vaara, Jorien De Loor, Mikko Haapio, Lieve Nuytinck, Kristel Demeyere, Ville Pettilä, Evelyne Meyer, The FINNAKI Study Group
Publikováno v:
Critical Care, Vol 24, Iss 1, Pp 1-10 (2020)
Abstract Background Acute kidney injury (AKI) is a frequently occurring syndrome in critically ill patients and is associated with worse outcomes. Biomarkers allow early identification and therapy of AKI which may improve outcomes. Urine chitinase 3-
Externí odkaz:
https://doaj.org/article/1472af90bd3640ccaf266ec78a96454b
Autor:
Sanna Törnblom, Sara Nisula, Liisa Petäjä, Suvi T. Vaara, Mikko Haapio, Eero Pesonen, Ville Pettilä, the FINNAKI study group
Publikováno v:
Annals of Intensive Care, Vol 10, Iss 1, Pp 1-10 (2020)
Abstract Background Neutrophil gelatinase-associated lipocalin (NGAL) is released from kidney tubular cells under stress as well as from neutrophils during inflammation. It has been suggested as a biomarker for acute kidney injury (AKI) in critically
Externí odkaz:
https://doaj.org/article/d14fd4d894cc403c9f4ab69117a008e5
Autor:
Renske Wiersema, Ruben J. Eck, Mikko Haapio, Jacqueline Koeze, Meri Poukkanen, Frederik Keus, Iwan C. C. van der Horst, Ville Pettilä, Suvi T. Vaara
Publikováno v:
BMC Nephrology, Vol 21, Iss 1, Pp 1-8 (2019)
Abstract Background Mortality rates associated with acute kidney injury (AKI) vary among critically ill patients. Outcomes are often not corrected for severity or duration of AKI. Our objective was to analyse whether a new variable, AKI burden, would
Externí odkaz:
https://doaj.org/article/4842baa8420d4ab694345704a3984cf7
Autor:
Hanna L. M. Rajala, Veli-Jukka Anttila, Mikko Haapio, Mikko A. I. Keränen, Ulla Wartiovaara-Kautto, Riikka Räty
Publikováno v:
Case Reports in Hematology, Vol 2021 (2021)
Gemtuzumab-ozogamicin (GO) is a humanized anti-CD33 antibody, which is conjugated to a cytotoxic calicheamicin. It is used to treat acute myeloid leukemia (AML) in combination with chemotherapy. We describe here two GO-treated acute myeloid leukemia
Externí odkaz:
https://doaj.org/article/3b672f54672f49918c8d96fb2cedac09
Publikováno v:
PLoS ONE, Vol 16, Iss 8, p e0256522 (2021)
BackgroundComorbidities are associated with increased mortality among patients receiving long-term kidney replacement therapy (KRT). However, it is not known whether primary kidney disease modifies the effect of comorbidities on KRT patients' surviva
Externí odkaz:
https://doaj.org/article/5b262b09e759420fbe2b83f3b6d40d53
Autor:
Panu Räty, Panu Mentula, Hanna Lampela, Taina Nykänen, Mikko Haapio, Tiina Lehtimäki, Markus B Skrifvars, Suvi T Vaara
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Introduction CT is the primary imaging option for acute abdominal pain in adults. Intravenous (IV) contrast media use improves CT quality but may cause post-contrast acute kidney injury (PC-AKI). Retrospective studies show no association between redu
Externí odkaz:
https://doaj.org/article/6a0efc20e183404484e53c37e7fe6eab
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Preeclampsia is a pregnancy-specific disorder affecting ca 3% of all pregnant women. Preeclampsia is the source of severe pregnancy complications. Later life consequences for mother and infant include increased risk of cardiovascular disease. Preecla
Externí odkaz:
https://doaj.org/article/deccd125f97e4d9ca13979af6587fadb